May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Bioactive -3 LCPUFA Derivatives, Resolvins and Neuroprotectins, Inhibit Neovascularization in Oxygen Induced Retinopathy
Author Affiliations & Notes
  • C. M. Aderman
    Department of Ophthalmology, Children's Hospital Boston, Boston, Massachusetts
  • K. M. Connor
    Department of Ophthalmology, Children's Hospital Boston, Boston, Massachusetts
  • J. Chen
    Department of Ophthalmology, Children's Hospital Boston, Boston, Massachusetts
  • A. Higuchi
    Department of Ophthalmology, Children's Hospital Boston, Boston, Massachusetts
  • J. P. SanGiovanni
    Division of Epidemiology and Clinical Research, National Eye Institute/NIH, Bethesda, Maryland
  • E. Y. Chew
    Division of Epidemiology and Clinical Research, National Eye Institute/NIH, Bethesda, Maryland
  • C. N. Serhan
    Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
  • N. N. Salem, Jr.
    Laboratory of Membrane Biochemistry and Biophysics, NIH/National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland
  • L. E. H. Smith
    Department of Ophthalmology, Children's Hospital Boston, Boston, Massachusetts
  • Footnotes
    Commercial Relationships C.M. Aderman, None; K.M. Connor, None; J. Chen, None; A. Higuchi, None; J.P. SanGiovanni, None; E.Y. Chew, None; C.N. Serhan, None; N.N. Salem, None; L.E.H. Smith, None.
  • Footnotes
    Support The V. Kann Rasmussen Foundation and NIH (EY008670 HIGHWIRE EXLINK_ID="48:5:3414:1" VALUE="EY008670" TYPEGUESS="GEN" /HIGHWIRE , EY017017 HIGHWIRE EXLINK_ID="48:5:3414:2" VALUE="EY017017" TYPEGUESS="GEN" /HIGHWIRE EY14811 (LEHS); 5 T32 EY07145 (KMC) P50-DE016191 HIGHWIRE EXLINK_ID="48:5:3414:3" VALUE="DE016191" TYPEGUESS="GEN" /HIGHWIRE , GM38765 (CNS)), CHB MRDDRC: P01 HD18655, Lew Wasserman Merit Award (LEHS)
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 3414. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. M. Aderman, K. M. Connor, J. Chen, A. Higuchi, J. P. SanGiovanni, E. Y. Chew, C. N. Serhan, N. N. Salem, Jr., L. E. H. Smith; Bioactive -3 LCPUFA Derivatives, Resolvins and Neuroprotectins, Inhibit Neovascularization in Oxygen Induced Retinopathy. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3414. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: The resolvins (resolution phase interaction products) and neuroprotectins (including neuroprotectinD1, NPD1) are bioactive products derived from the ω-3 long-chain polyunsaturated fatty acids (LCPUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Resolvins were first identified in resolving inflammatory exudates in tissues enriched with DHA. The contribution of resolvins and neuroprotectins in the regulation of angiogenesis has not yet been investigated. To determine if these bioactive products mediate the protective activities of ω-3 LCPUFAs against retinopathy, we assessed the role of resolvin family members, resolvinD1 (RvD1) and RvE1 and NPD1 in both vessel loss and pathological neovascularization in a mouse model of oxygen induced retinopathy.

Methods:: A physiological dose of NPD1, RvD1, RvE1 or saline (control) was administered intraperitoneally from postnatal day 6 (P6) to P17 or from P5 to P8 (10ng/day, comparable to levels found in the retinas of mice fed a physiologically elevated ω-3 LCPUFA diet). NPD1, RvD1, and RvE1 were not detected in the retinas of ω-6 LCPUFA fed mice. To induce vessel loss, mice were exposed to 75% O2 from P7 to P12. Mice were sacrificed at P8 or P17. Retinas were stained with lectin and flatmounted for visualization with confocal microscopy. Vaso-obliteration (at P8 and P17) and neovascular tuft areas (at P17) for each bioactive compound were quantified and compared with the saline control.

Results:: RvD1-, RvE1- and NPD1-treated mice showed significantly reduced vaso-obliteration, (p≤0.0001) and neovascularization (p≤0.03) at P17 compared to saline controls. No differences in vessel loss were observed between RvD1, RvE1 or NPD1 treated mice and controls treated from P5 to P8, indicating that these ω-3 LCPUFA derivatives confer their protective actions against retinopathy via enhanced vessel re-growth, not protection from vessel loss.

Conclusions:: These findings suggest that the bioactive ω-3 LCPUFA derivatives RvD1, RvE1 and NPD1 are potent suppressors of retinal angiogenesis and serve their protective effect through modulation of vessel regrowth after vessel loss.

Keywords: neovascularization • lipids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×